News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Northeast U.S. Has Most Brain Cancer Hospitalization By Agency for Healthcare Research and Quality


Posted on: 03/04/2009

Northeast U.S. Has Most Brain Cancer Hospitalization
By Agency for Healthcare Research and Quality
Mar 4, 2009 - 3:14:01 PM

( - People in the Northeastern U.S. are one-third more likely than those in the South or West to be hospitalized for treatment of brain cancer or to have brain cancer when they are hospitalized for another illness or complication, according to the latest News and Numbers from the U.S. Agency for Healthcare Research and Quality.

In 2006, about 30 of every 100,000 people in the Northeast were hospitalized with brain cancer. That compares to 23 per 100,000 for people in both the South and West. The rate was slightly higher for people in the Midwest – 25 per 100,000.

AHRQ’s analysis also shows that in 2006:

Nationally, the hospitalization rate for brain cancer remained stable since 1995 – roughly about 35,000 hospital stays a year.
An additional 38,000 hospital admissions were associated with brain cancer – mostly for chemotherapy or radiotherapy to continue treatment, or for convulsions, pneumonia or other complication from the disease. These hospitalizations increased 18 percent since 1995.

Among people over 65, men were 62 percent more likely to be hospitalized primarily for brain cancer and 55 percent more likely to be hospitalized with brain cancer as a secondary diagnosis than were women.

While 6.2 percent of hospital patients admitted for brain cancer died while hospitalized in 1995, the rate dropped to 4.4 percent in 2006.

This AHRQ News and Numbers is based on data in Hospitalizations for Brain Cancer, 2006. The report uses statistics from the 2006 Nationwide Inpatient Sample, a database of hospital inpatient stays that is nationally representative of inpatient stays in all short-term, non-Federal hospitals. The data are drawn from hospitals that comprise 90 percent of all discharges in the United States and include all patients, regardless of insurance type, as well as the uninsured.

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557